ArticleLancet regional health. Americas2025
A time-series analysis of the use of opioid medications in a network of Brazilian hospitals, 2009-2020.
Article in Lancet regional health. Americas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Emerging Burden of Opioid Poisoning in Brazil, 2019-2025: A Nationwide Epidemiological and Toxicovigilance Analysis.Pharmaceuticals (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To date, no studies in Brazil have described the profile of hospital opioid use. This study aimed to describe the temporal evolution of opioid consumption in hospitalised patients in a Brazilian hospital network. Methods: This study describes a 12-year time-series (2009-2020) of hospital use of opioids in 28 hospitals of a private network in Brazil. More than four million prescriptions were analyzed using the Findings: Parenteral tramadol was the most consumed opioid, followed by parenteral fentanyl and parenteral morphine. Among enteral opioids, the most commonly used was codeine followed by tramadol. There were several variations in the use patterns for most medications, with periods of significant increases and decreases, but two opioids underwent considerable change: parenteral fentanyl, which doubled in consumption, especially during the COVID-19 pandemic, and enteral tramadol, which had a fourfold reduction over time. Enteral oxycodone, the pivot of the opioid crisis in the USA, was relatively little used in this series. Methadone, both parenteral and enteral, was seldom used at the hospitals under analysis, an indicator of a mild use of other opioids, before and/or during hospitalisation. Interpretation: Knowledge and documentation of the utilisation profile of this class of medication is relevant, given the concern that any increase in consumption at any point in the chain, including during hospitalisations, may trigger events of increased outpatient opioid use and potential misuse. Funding: Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ, grant E-26/010.002428/2019) and IDORDepartment of Pediatrics, Rio de Janeiro, RJ, Brazil.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.